20
Granules India Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for World-class facilities for APIs, PFIs & FDFs, Serving customers in over 75+ countries.
One of their significant offerings is Naproxen sodium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2020-106 - Rev 00
This Chemical Type CEP, issued on June 28, 2021, remains in force until September 11, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1702 associated with this CEP further emphasizes